Two main strategies have been used to modify the sequences of semaglutide and tirzepatide (red circles) and increase their bioavailability: 1) removal of the DPP-4 cleavage site, replacing alanine with an analogous molecule (-aminoisobutyric acid (Aib)), but not recognized by the enzyme
Cheenpracha S, Park EJ, Yoshida WY, Barit C, Wall M, Pezzuto JM, Chang LC
A 40% reduction in triglycerides is what wed expect with a class of medications called fibrates
Summary of Storage Conditions
Its amino acid seque nce is Gly-Glu-Pro-Pro-Pro- Gly-Lys-Pro-Ala-Asp-Asp-Ala- Gly-Leu-Val
Tirzepatide causes nausea in roughly 39% of users, predominantly during dose escalation